S-adenosyl-L-methionine decarboxylase during lymphocyte transformation: decreased degradation in the presence of a specific inhibitor.
D000578:Amidines / Q000494:pharmacology; D000818:Animals; D002247:Carbon Isotopes; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D002417:Cattle; D002474:Cell-Free System; D002478:Cells, Cultured; D003208:Concanavalin A / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology; D004355:Drug Stability; D006037:Glyoxal / Q000494:pharmacology; D006835:Hydrazones / Q000494:pharmacology; D007700:Kinetics; D037102:Lectins / Q000494:pharmacology*; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000166:cytology / Q000187:drug effects / Q000201:enzymology; D012436:S-Adenosylmethionine; D013997:Time Factors; D014316:Tritium
D000578:Amidines; D002247:Carbon Isotopes; D006835:Hydrazones; D037102:Lectins; D014316:Tritium; D003208:Concanavalin A; D006037:Glyoxal; D012436:S-Adenosylmethionine; D003513:Cycloheximide; D002262:Carboxy-Lyases